Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 25, 2026 | UnitedHealthcare | Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical TrialsPayerPolicy · UHC-COMM-MD-MANDATORY-MEDICAID-COVERAGE-QUALIFYING-CLINICAL-TRIALS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Luxturna (Voretigene Neparvovec-Rzyl) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-LUXTURNA-VORETIGENE-NEPARVOVEC-RZYL-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Lower Extremity ProstheticsPayerPolicy · UHC-COMM-MD-LOWER-EXTREMITY-PROSTHETICS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Lower Extremity Endovascular ProceduresPayerPolicy · UHC-COMM-MD-LOWER-EXTREMITY-VASCULAR-ANGIOGRAPHY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Long-Acting Injectable Antiretroviral Agents for HIV – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-LONG-ACTING-INJECTABLE-ANTIRETROVIRAL-AGENTS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Liposuction for LipedemaPayerPolicy · UHC-COMM-MD-LIPOSUCTION-FOR-LIPEDEMA-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Light and Laser TherapyPayerPolicy · UHC-COMM-MD-LIGHT-LASER-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Leqvio (Inclisiran) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-LEQVIO-INCLISIRAN-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Lemtrada (Alemtuzumab) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-LEMTRADA-ALEMTUZUMAB-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Krystexxa (Pegloticase) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-KRYSTEXXA-PEGLOTICASE-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Korsuva (Difelikefalin) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-KORSUVA-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Ketalar (Ketamine) and Spravato (Esketamine) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-KETALAR-SPRAVATO-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Kebilidi (Eladocagene Exuparvovec-Tneq) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-KEBILIDITM-ELADOCAGENE-EXUPARVOVEC-TNEQ-5F8D97842B | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Intravenous Iron Replacement Therapy (Feraheme, Injectafer, & Monoferric) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-IV-IRON-REPLACEMENT-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Intravenous Enzyme Replacement Therapy (ERT) for Gaucher Disease – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-INTRAVENOUS-ENZYME-REPLACEMENT-THERAPY-GAUCHER-DISEASE-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Intracanalicular and Intravitreal Corticosteroid Implants – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-INTRAVITREAL-CORTICOSTEROID-IMPLANTS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Interspinous Fusion and Decompression DevicesPayerPolicy · UHC-COMM-MD-INTERSPINOUS-FUSION-DECOMPRESSION-DEVICES-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Intensity-Modulated Radiation TherapyPayerPolicy · UHC-COMM-MD-INTENSITY-MODULATED-RADIATION-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Injectable Dermal Fillers and Bulking AgentsPayerPolicy · UHC-COMM-MD-INJECTABLES-RECONSTRUCTIVE-PROCEDURES-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Inhaled Nitric Oxide TherapyPayerPolicy · UHC-COMM-MD-INHALED-NITRIC-OXIDE-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Infliximab – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-INFLIXIMAB-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Implanted Electrical Stimulator for the Spinal CordPayerPolicy · UHC-COMM-MD-IMPLANTED-ELECTRICAL-STIMULATOR-SPINAL-CORD-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Implantable Loop Recorders and Wearable Heart Rhythm MonitorsPayerPolicy · UHC-COMM-MD-IMPLANTABLE-RECORDERS-WEARABLE-MONITORS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Immune Globulin (IVIG and SCIG) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-IMMUNE-GLOBULIN-IVIG-SCIG-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Ilumya (Tildrakizumab-Asmn) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-ILUMYA-TILDRAKIZUMAB-ASMN-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Ilaris (Canakinumab) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-ILARIS-CANAKINUMAB-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | HysterectomyPayerPolicy · UHC-COMM-MD-HYSTERECTOMY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Hospital Services: Observation and InpatientPayerPolicy · UHC-COMM-MD-HOSPITAL-SERVICES-OBSERVATION-INPATIENT-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Home Traction TherapyPayerPolicy · UHC-COMM-MD-HOME-TRACTION-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Home Health, Skilled, and Custodial Care ServicesPayerPolicy · UHC-COMM-MD-HOME-HEALTH-CARE-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Hereditary Angioedema (HAE), Treatment and Prophylaxis – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-HEREDITARY-ANGIOEDEMA-TREATMENT-PROPHYLAXIS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-ImplantablePayerPolicy · UHC-COMM-MD-HEARING-AIDS-DEVICES-INCLUDING-WEARABLE-BONE-ANCHORED-SEMI-IMPLANTABLE-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech) – Site of Service (for Florida Only)PayerPolicy · UHC-COMM-MD-HABILITATION-REHABILITATION-THERAPY-SOS-FL-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech)PayerPolicy · UHC-COMM-MD-HABILITATION-REHABILITATION-THERAPY-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech) (for Florida Only)PayerPolicy · UHC-COMM-MD-HABILITATION-REHABILITATION-THERAPY-FL-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gynecomastia SurgeryPayerPolicy · UHC-COMM-MD-GYNECOMASTIA-TREATMENT-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gynecomastia Surgery (for Florida Only)PayerPolicy · UHC-COMM-MD-GYNECOMASTIA-TREATMENT-FL-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gonadotropin Releasing Hormone Analogs – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-GONADOTROPIN-RELEASING-HORMONE-ANALOGS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Glaucoma Surgical TreatmentsPayerPolicy · UHC-COMM-MD-GLAUCOMA-SURGICAL-TREATMENTS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Givlaari (Givosiran) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-GIVLAARI-GIVOSIRAN-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Genetic Testing for Neurological DisordersPayerPolicy · UHC-COMM-MD-GENETIC-TESTING-NEUROMUSCULAR-DISORDERS-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Genetic Testing for Hereditary CancerPayerPolicy · UHC-COMM-MD-GENETIC-TESTING-HEREDITARY-CANCER-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Genetic Testing for Cardiac DiseasePayerPolicy · UHC-COMM-MD-GENETIC-TESTING-CARDIAC-DISEASE-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gene Therapies for Hemophilia B – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-GENE-THERAPIES-FOR-HEMOPHILIA-B-COMMUNIT-FE4957963B | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gender Dysphoria TreatmentPayerPolicy · UHC-COMM-MD-GENDER-DYSPHORIA-TREATMENT-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gazyva (Obinutuzumab) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-GAZYVA-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing for Infectious DiarrheaPayerPolicy · UHC-COMM-MD-GASTROINTESTINAL-PATHOGEN-TESTING-INFECTIOUS-DIARRHEA-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gastrointestinal Disorders Diagnostic ProceduresPayerPolicy · UHC-COMM-MD-GASTROINTESTINAL-MOTILITY-DISORDERS-DIAGNOSIS-TREATMENT-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Gamifant (Emapalumab-Lzsg) – Community Plan Medical Benefit Drug PolicyPayerPolicy · UHC-COMM-MD-GAMIFANT-EMAPALUMAB-LZSG-CS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | FDA Cleared or Approved Companion Diagnostic TestingPayerPolicy · UHC-COMM-MD-FDA-COMPANION-DIAGNOSTIC-TESTING-CS | New policy |
|---|